GoodRx Holdings reports Q3 results on November 4, trading at $3.55 after a quiet month that saw shares gain just over 8% while short sellers retreated sharply from the stock. The retreat in short interest is the clearest change in the setup. Shorts have covered roughly a quarter of their position over the past month, with SI falling to 3.4% of the free float from levels above 4.5%…
GDRX cost to borrow surges to 0.60%, up 579% over the past week as short interest falls.
Key data as of 12 Nov 2026
GDRX cost to borrow surges to 0.60%, up 579% over the past week as short interest falls.
GoodRx Holdings heads into its Q1 2026 earnings print on May 7 with short sellers piling in at a pace not seen in months — even as the stock itself has quietly rallied 10% this week. The tension is stark. Short…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for GDRX — free to start on ORTEX.
Sign up for free →Open GDRX on ORTEX